sufentanil + propofol + midazolam

This is a combination of three drugs—sufentanil, propofol, and midazolam—used together for procedural sedation and anesthesia. Sufentanil is a potent synthetic opioid analgesic that acts primarily as a mu-opioid receptor agonist, providing strong pain relief. Propofol is an intravenous anesthetic agent known for its rapid onset and short duration of action; it induces hypnosis by potentiating GABA-A receptor activity in the central nervous system. Midazolam is a short-acting benzodiazepine that enhances the effect of GABA at the GABA-A receptor, producing anxiolytic, amnestic, muscle relaxant, anticonvulsant, and sedative effects. The combination aims to synergistically provide sedation (midazolam), hypnosis (propofol), and analgesia (sufentanil), allowing for effective procedural sedation with potentially lower doses of each drug compared to monotherapy or dual therapy regimens[6][9][10]. This triple regimen may be used in settings such as endoscopy or surgery where deep sedation with rapid recovery is desired.